210 related articles for article (PubMed ID: 36258192)
1. A systematic review of strategies used for controlling consumer moral hazard in health systems.
Koohi Rostamkalaee Z; Jafari M; Gorji HA
BMC Health Serv Res; 2022 Oct; 22(1):1260. PubMed ID: 36258192
[TBL] [Abstract][Full Text] [Related]
2. Demand-side Interventions to Control Moral Hazard in Health Systems, Beneficial or Detrimental: A Systematic Review Study.
Koohi Rostamkalaee Z; Jafari M; Gorji HA
Med J Islam Repub Iran; 2022; 36():69. PubMed ID: 36128264
[No Abstract] [Full Text] [Related]
3. Moral hazard and consumer-driven health care: a fundamentally flawed concept.
Geyman JP
Int J Health Serv; 2007; 37(2):333-51. PubMed ID: 17665727
[TBL] [Abstract][Full Text] [Related]
4. The moral hazard effects of consumer responses to targeted cost-sharing.
Whaley CM; Guo C; Brown TT
J Health Econ; 2017 Dec; 56():201-221. PubMed ID: 29111500
[TBL] [Abstract][Full Text] [Related]
5. Demand-side financing measures to increase maternal health service utilisation and improve health outcomes: a systematic review of evidence from low- and middle-income countries.
Murray SF; Hunter BM; Bisht R; Ensor T; Bick D
JBI Libr Syst Rev; 2012; 10(58):4165-4567. PubMed ID: 27820523
[TBL] [Abstract][Full Text] [Related]
6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
7. How do moral hazard behaviors lead to the waste of medical insurance funds? An empirical study from China.
Qin Y; Liu J; Li J; Wang R; Guo P; Liu H; Kang Z; Wu Q
Front Public Health; 2022; 10():988492. PubMed ID: 36388392
[TBL] [Abstract][Full Text] [Related]
8. Which moral hazard? Health care reform under the Affordable Care Act of 2010.
Mendoza RL
J Health Organ Manag; 2016 Jun; 30(4):510-29. PubMed ID: 27296875
[TBL] [Abstract][Full Text] [Related]
9. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.
Mendoza RL
J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric Information in Iranian's Health Insurance Market: Testing of Adverse Selection and Moral Hazard.
Lotfi F; Abolghasem Gorji H; Mahdavi G; Hadian M
Glob J Health Sci; 2015 Apr; 7(6):146-55. PubMed ID: 26153155
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.
Luiza VL; Chaves LA; Silva RM; Emmerick IC; Chaves GC; Fonseca de Araújo SC; Moraes EL; Oxman AD
Cochrane Database Syst Rev; 2015 May; 2015(5):CD007017. PubMed ID: 25966337
[TBL] [Abstract][Full Text] [Related]
12. Study of the ex-post moral hazard of laboratory services in Iran.
Otobideh SA; Yusefzadeh H; Aghlmand S; Alinia C
Health Policy Open; 2021 Dec; 2():100031. PubMed ID: 37383515
[TBL] [Abstract][Full Text] [Related]
13. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
[TBL] [Abstract][Full Text] [Related]
14. The influential factors for achieving universal health coverage in Iran: a multimethod study.
Derakhshani N; Maleki M; Pourasghari H; Azami-Aghdash S
BMC Health Serv Res; 2021 Jul; 21(1):724. PubMed ID: 34294100
[TBL] [Abstract][Full Text] [Related]
15. American health policy: cracks in the foundation.
Nyman JA
J Health Polit Policy Law; 2007 Oct; 32(5):759-83. PubMed ID: 17855716
[TBL] [Abstract][Full Text] [Related]
16. Incentivizing efficient utilization without reducing access: The case against cost-sharing in insurance.
Fels M
Health Econ; 2020 Jul; 29(7):827-840. PubMed ID: 32319145
[TBL] [Abstract][Full Text] [Related]
17. Insurance companies' point of view toward moral hazard incentives.
Khorasani E; Keyvanara M; Etemadi M; Asadi S; Mohammadi M; Barati M
J Med Ethics Hist Med; 2016; 9():12. PubMed ID: 28050242
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of and reasons for women's, family members', and health professionals' preferences for cesarean section in Iran: a mixed-methods systematic review.
Shirzad M; Shakibazadeh E; Hajimiri K; Betran AP; Jahanfar S; Bohren MA; Opiyo N; Long Q; Kingdon C; Colomar M; Abedini M
Reprod Health; 2021 Jan; 18(1):3. PubMed ID: 33388072
[TBL] [Abstract][Full Text] [Related]
19. Reconsidering the moral hazard-risk avoidance tradeoff.
Newhouse JP
J Health Econ; 2006 Sep; 25(5):1005-14. PubMed ID: 16860893
[TBL] [Abstract][Full Text] [Related]
20. Deductibles in Health Insurance, Beneficial or Detrimental: A Review Article.
Mirian I; Kabir MJ; Barati O; Keshavarz K; Bastani P
Iran J Public Health; 2020 May; 49(5):851-859. PubMed ID: 32953673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
